CD28 Costimulation: From Mechanism to Therapy
Open Access
- 1 May 2016
- journal article
- review article
- Published by Elsevier BV in Immunity
- Vol. 44 (5), 973-988
- https://doi.org/10.1016/j.immuni.2016.04.020
Abstract
No abstract availableThis publication has 212 references indexed in Scilit:
- CD28 Aptamers as Powerful Immune Response ModulatorsMolecular Therapy Nucleic Acids, 2013
- A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28Nature Immunology, 2011
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- B7-H2 Is a Costimulatory Ligand for CD28 in HumanImmunity, 2011
- Sustained CD28 Expression Delays Multiple Features of Replicative Senescence in Human CD8 T LymphocytesJournal of Clinical Immunology, 2010
- Remapping the type I diabetes association of the CTLA4 locusGenes & Immunity, 2009
- Development of Foxp3+ Regulatory T Cells Is Driven by the c-Rel EnhanceosomeImmunity, 2009
- Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis riskNature Genetics, 2009
- Spatiotemporal Regulation of T Cell Costimulation by TCR-CD28 Microclusters and Protein Kinase C θ TranslocationImmunity, 2008
- Allelic variant inCTLA4alters T cell phosphorylation patternsProceedings of the National Academy of Sciences, 2007